Clinical Trials in North Carolina

Showing 381-400 of 20,428 trials

Appalachian Partnership to Reduce Disparities (Aim 2)

NCT04378439

By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care services among racially/ethnically diverse GBMSM and transgender women in rural Appalachia. Study Investigators anticipate that participants in the intervention group, relative to counterparts in the delayed-intervention group, will demonstrate increased HIV, STI, and HCV testing.

HIV/AIDSSTIHCV

Wake Forest University Health Sciences141 participantsStarted Apr 2022

Winston-Salem, North Carolina, United States

COMPLETEDNA41 miles

Transtibial Amputation Outcomes Study

NCT01821976

The goals of the TAOS study is to determine the best procedures for below the knee amputations. There are two different procedures currently used by surgeons around the county: the Erlt procedure and the Burgess procedure. Proponents of the Ertl procedure advocate that the surgical formation of a tibia to fibula bone bridge provides stability, shape and weight bearing capability to the residual limb that result in less pain and better prosthetic fit and alignment. This procedure is popular especially among the military but it's advantages over the Burgess procedure are not well supported by current research. This study aims to compare the two amputation procedures in an adequately powered randomized trial.

Transtibial Amputation

Major Extremity Trauma Research Consortium199 participantsStarted Mar 2013

San Francisco, California, United States • Miami, Florida, United States • Tampa, Florida, United States +20 more locations

Appalachian Partnership to Reduce Disparities (Aim 2)

Transtibial Amputation Outcomes Study

Find Trials by Condition in North Carolina

NIBP Validation Study

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder

A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma

Galleri® in the Medicare Population.

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

Genomic Predictors of Recurrent Pregnancy Loss

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

A Study of LY3502970 in Participants With Type 2 Diabetes

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)